Promoter CpG methylation of HLTF and HPP1/TPEF were found to be correlated with tumour size, metastatic disease and tumour stage with multivariate analysis indicating strong association with poor outcome [117,118,119]. Here, TMEFF2 is linked to metastatic neoplasm.